Elotuzumab (anti-SLAMF7)
A2034
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameElotuzumab (anti-SLAMF7)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionElotuzumab (anti-SLAMF7, BMS-901608, PDL063, HuLuc63) is a humanized monoclonal antibody that binds human signaling lymphocytic activation molecule F7 (hSLAMF7, also known as CS1, CD319, or CRACC). Elotuzumab shows a dual mechanism of action that includes the direct activation of natural killer (NK) cells and the induction of NK cell-mediated antibody-dependent cellular cytotoxicity.
- Storage Instruction2°C to 8°C
- UNSPSC12352203